C.R. Pace-Asciak

7.5k total citations · 1 hit paper
188 papers, 6.1k citations indexed

About

C.R. Pace-Asciak is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, C.R. Pace-Asciak has authored 188 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pharmacology, 66 papers in Molecular Biology and 53 papers in Biochemistry. Recurrent topics in C.R. Pace-Asciak's work include Inflammatory mediators and NSAID effects (58 papers), Eicosanoids and Hypertension Pharmacology (52 papers) and Pharmacogenetics and Drug Metabolism (31 papers). C.R. Pace-Asciak is often cited by papers focused on Inflammatory mediators and NSAID effects (58 papers), Eicosanoids and Hypertension Pharmacology (52 papers) and Pharmacogenetics and Drug Metabolism (31 papers). C.R. Pace-Asciak collaborates with scholars based in Canada, United States and Kuwait. C.R. Pace-Asciak's co-authors include L. S. Wolfe, Eleftherios P. Diamandis, David M. Goldberg, Susan Hahn, Dénis Reynaud, Godha Rangaraj, George J. Soleas, Peter Demin, M.C. Carrara and J. M. Martin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

C.R. Pace-Asciak

188 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease

1995 715 citations C.R. Pace-Asciak et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.R. Pace-Asciak Canada	42	2.0k	1.7k	1.7k	1.1k	892	188	6.1k
Dennis R. Petersen United States	53	4.4k 2.2×	466 0.3×	1.0k 0.6×	1.4k 1.3×	630 0.7×	177	9.2k
Pedro M. Fernández‐Salguero Spain	56	6.4k 3.2×	450 0.3×	720 0.4×	1.2k 1.1×	2.0k 2.3×	118	12.7k
Norbert Latruffe France	44	4.4k 2.2×	411 0.2×	433 0.3×	1.3k 1.2×	265 0.3×	194	7.7k
Anna–Liisa Levonen Finland	44	5.7k 2.8×	559 0.3×	986 0.6×	1.2k 1.1×	224 0.3×	99	8.8k
José M. Estrela Spain	44	3.1k 1.5×	241 0.1×	1.1k 0.7×	733 0.7×	232 0.3×	88	6.5k
Richard Lehner Canada	40	2.2k 1.1×	484 0.3×	1.9k 1.1×	1.2k 1.1×	229 0.3×	91	5.1k
Wen‐Xing Ding United States	52	3.3k 1.7×	931 0.5×	533 0.3×	698 0.6×	1.4k 1.5×	141	8.5k
Thomas W. Doebber United States	34	6.0k 3.0×	579 0.3×	674 0.4×	2.4k 2.2×	183 0.2×	58	9.1k
Yasutake Katoh Japan	24	10.8k 5.4×	410 0.2×	745 0.4×	848 0.8×	482 0.5×	32	12.9k
Anna Colell Spain	50	4.9k 2.4×	250 0.1×	1.3k 0.8×	1.4k 1.3×	535 0.6×	93	8.8k

Countries citing papers authored by C.R. Pace-Asciak

Since Specialization

Citations

This map shows the geographic impact of C.R. Pace-Asciak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.R. Pace-Asciak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.R. Pace-Asciak more than expected).

Fields of papers citing papers by C.R. Pace-Asciak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.R. Pace-Asciak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.R. Pace-Asciak. The network helps show where C.R. Pace-Asciak may publish in the future.

Co-authorship network of co-authors of C.R. Pace-Asciak

This figure shows the co-authorship network connecting the top 25 collaborators of C.R. Pace-Asciak. A scholar is included among the top collaborators of C.R. Pace-Asciak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.R. Pace-Asciak. C.R. Pace-Asciak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pace-Asciak, C.R.. (2014). Pathophysiology of the hepoxilins. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(4). 383–396. 36 indexed citations

Pace-Asciak, C.R., Xiang Li, Dénis Reynaud, et al.. (2013). Alterations in eicosanoid levels during U937 bcl-xL tumour growth suppression and recovery in NU/NU mice in vivo—Involvement of phospholipase A2. Prostaglandins & Other Lipid Mediators. 107. 43–47. 1 indexed citations

Estey, Mathew P., et al.. (2007). Sept12 is a component of the mammalian sperm tail annulus. Cell Motility and the Cytoskeleton. 64(10). 794–807. 58 indexed citations

Huang, Yiwei, Mark C. Surka, Dénis Reynaud, C.R. Pace-Asciak, & William S. Trimble. (2006). GTP binding and hydrolysis kinetics of human septin 2. FEBS Journal. 273(14). 3248–3260. 54 indexed citations

Hanson, Julien, Stéphanie Rolin, Dénis Reynaud, et al.. (2005). In Vitro and in Vivo Pharmacological Characterization of BM-613 [N-n-Pentyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a Novel Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 313(1). 293–301. 11 indexed citations

Belik, Jaques, Robert P. Jankov, Jingyi Pan, et al.. (2003). Effect of 8-isoprostaglandin F_2αon the newborn rat pulmonary arterial muscle and endothelium. Journal of Applied Physiology. 95(5). 1979–1985. 21 indexed citations

Pace-Asciak, C.R., et al.. (2002). A New Family of Thromboxane Receptor Antagonists with Secondary Thromboxane Synthase Inhibition. Journal of Pharmacology and Experimental Therapeutics. 301(2). 618–624. 14 indexed citations

Nigam, Santosh, et al.. (1999). Lipoxygenases and their metabolites : biological functions. 9 indexed citations

Pace-Asciak, C.R., et al.. (1999). Hepoxilin A3 is Metabolized Into its ω-Hydroxy Metabolite by Human Neutrophils. Advances in experimental medicine and biology. 469. 535–538. 3 indexed citations

10.

Al‐Hassan, Jassim M., M. Ali, Martha Thomson, & C.R. Pace-Asciak. (1998). Detection of 8-epi prostaglandin F2α in an extract of epidermal secretion of the catfish from the arabian gulf. Prostaglandins Leukotrienes and Essential Fatty Acids. 59(5). 325–328. 8 indexed citations

11.

Reynaud, Dénis & C.R. Pace-Asciak. (1997). Docosahexaenoic acid causes accumulation of free arachidonic acid in rat pineal gland and hippocampus to form hepoxilins from both substrates. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1346(3). 305–316. 16 indexed citations

12.

Demin, Peter, et al.. (1996). Epimer-Specific Actions of Hepoxilins A3 and B3 on PAF- and Bradykinin-Evoked Vascular Permeability in the Rat Skin in Vivo. Advances in experimental medicine and biology. 416. 239–241. 6 indexed citations

13.

Demin, Peter, Dénis Reynaud, & C.R. Pace-Asciak. (1995). Extractive Derivatization of the 12-Lipoxygenase Products, Hepoxilins, and Related Compounds into Fluorescent Anthryl Esters for Their Complete High-Performance Liquid Chromatography Profiling in Biological Systems. Analytical Biochemistry. 226(2). 252–255. 13 indexed citations

14.

Pace-Asciak, C.R.. (1993). Hepoxilins. General Pharmacology The Vascular System. 24(4). 805–810. 24 indexed citations

15.

Pace-Asciak, C.R., Dénis Reynaud, & Peter Demin. (1993). Enzymatic Formation of Hepoxilins A3 and B3. Biochemical and Biophysical Research Communications. 197(2). 869–873. 16 indexed citations

16.

Laneuville, Odette, E. J. Corey, Réjean Couture, & C.R. Pace-Asciak. (1991). Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1084(1). 60–68. 29 indexed citations

17.

Pace-Asciak, C.R. & Santosh Nigam. (1991). Hepoxilins Modulate Second Messenger Systems in the Human Neutrophil. Advances in experimental medicine and biology. 314. 133–139. 6 indexed citations

18.

Nigam, Santosh, et al.. (1990). Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils. Biochemical and Biophysical Research Communications. 171(3). 944–948. 44 indexed citations

19.

Carlen, Peter L., N. Gurevich, P.H. Wu, et al.. (1989). Actions of arachidonic acid and hepoxilin A3 on mammalian hippocampal CA1 neurons. Brain Research. 497(1). 171–176. 67 indexed citations

20.

Ferdinandi, Eckhardt S., Mitchell N. Cayen, & C.R. Pace-Asciak. (1982). Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.. Journal of Pharmacology and Experimental Therapeutics. 220(2). 417–426. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact